PDG11 COST MINIMIZATION ANALYSIS OF TRASTUZUMAB SUBCUTANEOUS VERSUS INTRAVENOUS IN TREATMENT OF HER2-POSITIVE EARLY OR METASTATIC BREAST CANCER IN VIETNAM
May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.301
https://www.valueinhealthjournal.com/article/S1098-3015(20)30489-7/fulltext
Section Title :
Section Order :
10163
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30489-7&doi=10.1016/j.jval.2020.04.301